A Pocket-Sized MRI for strokes? new device put to the test
NCT ID NCT07751328
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial evaluates the safety and feasibility of a portable, low-field MRI device called Axana for imaging the brain in people with suspected stroke. Researchers will compare scans from the Axana device with standard hospital MRI scans in 60 adults, including healthy volunteers and stroke patients. The goal is to see if the portable device can produce usable images quickly and safely at the bedside, which could speed up stroke diagnosis and treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Axana portable MRI device
- What this could lead to
- If successful, this portable MRI could enable faster, bedside stroke diagnosis, potentially improving outcomes in emergency and remote settings.
- What could go wrong
- This is an early feasibility study with a small number of participants. The device may not match the image quality of standard MRI, and technical failures or usability issues could limit its use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Sep 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Healthy Participants: * Adults aged 18 years or older. * Able to undergo an in-hospital MRI scan. * Able to provide informed consent. * Head size considered suitable for scanning with the Wellumio Axana brain scanner. Hospital Patients: * Adults aged 18 years or older. * Presenting to hospital with an acute neurological deficit suspected to be stroke within 24 hours of symptom onset. * Clinical and radiological diagnosis of stroke, including ischemic stroke, haemorrhagic stroke, or subarachnoid haemorrhage. * Able to undergo an in-hospital MRI scan. * Up to 72 hours post-acute stroke. * Able to provide written informed consent or, where this is not possible, informed consent provided by a legally authorised representative. * Head size considered suitable for scanning with the Wellumio Axana brain scanner. Exclusion Criteria: General: * Pregnant or breastfeeding. * Contraindication to neuroimaging, including any condition that prohibits MRI. * Presence of an implanted electro-stimulating device in the head or neck. * Presence of a large metallic craniofacial implant, such as a bone fixation plate or mesh. Small metallic objects, such as aneurysm coils, are acceptable. * Presence of an intracranial pressure monitor or another similar sensor that may compromise placement of the investigational device. * Inability to wear the investigational device, including because of scalp skin lesions or previous intracranial surgery. * Unable to lie still for the duration of the scan. * Any other condition or symptom that, in the investigator's judgement, prevents participation in the study. * Unable to provide informed consent and, where applicable, consent cannot be obtained from a legally authorised representative. Healthy Participants: * History of a neurological condition, including brain tumour, previous stroke, or neurological trauma. * Post-study MRI findings indicating a brain condition associated with structural changes.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Melbourne Hospital, also known as RMH Parkville
Melbourne, Victoria, 3052, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Zapping the spine while wearing a robotic ankle: a new way to help kids walk?
- Can a nurse and a neighbor help tame chronic disease?
- Can PET scans reveal hidden heart inflammation after a stroke?
- Two ways to catch a hidden heart rhythm after stroke